Alberto Corigliano introduces the ERC Advanced Grant project IMMENSE, which aims to overcome the challenge of developing ...

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Ambiq Micro, Inc. (NYSE:AMBQ) Q4 2025 Earnings Call Transcript March 5, 2026 Ambiq Micro, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.39. Operator: Good morning, ...

On today’s call, Ambiq Micro, Inc.’s CEO, Fumihide Esaka, will provide an overview of the company’s performance and strategy.

Elia addressed the DECLARATION study for VYD2311: "We were recently notified that the DECLARATION clinical trial has reached target enrollment...may modestly over enroll as sites are permission to ...

Q4 2025 Earnings Call March 5, 2026 8:30 AM ESTCompany ParticipantsCharlene Wan - Vice President of Corporate Marketing ...

A targeted review of the Australian F-2 mathematics curriculum is now underway to address poor numeracy standards amongst primary students - and it comes with a controversial new priority.

Earnings call Profound Medical reported Q4 2025 revenue of CAD 6 million, up 43% year-over-year, with gross margin at 67% and a net loss of CAD 8.2 million. Management anticipates continued high ...